CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PharmaTimes
Original article

Heparegenix completes first darizmetinib treatment in phase 1b

Phase 1darizmetinibPositive
AI Analysis

Summary

Heparegenix has completed the first patient treatment with darizmetinib in a Phase 1b trial and is preparing to advance into Phase 2a development.

Clinical Trial Data

Phase

1b

Importance:4/10
Sentiment:
0.50
Phase 1bClinical TrialFirst Patient DosedTransition to Phase 2
Related Companies

Read the original article

Published by PharmaTimes on September 24, 2026 10:01 AM

Read Original